findmyKOL

Liza Gill, MD

Basic profile

Henry Ford Health

ORCIDNone on fileNPI↗
✓ Full record
RegionVictorville, CA · WestSpecialtyDermatologyFocusDermatology
Active KOLfindmyKOL type: RegionalLatest publication2015Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Liza Gill is a Dermatology physician affiliated with Henry Ford Health. OpenAlex indexes 6 publications with 286 citations (h-index 4).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
6publications

Distinct works indexed by OpenAlex.

286citations

Total citations across indexed works.

4h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
15companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

12565 Hesperia Rd Ste 3
Victorville, CA 923958318

Telephone

760-780-0003

Provider last certified this registry record 4 Feb 2024.

View the NPPES registry record

Industry payments

15 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Anti-infectives

    38.6%
    Azole Antifungal19.2%
    Ketoconazole100%
    Part D≥66 patients
    First-generation cephalosporins10.3%
    Cephalexin100%
    Part D≥56 patients

    + 2 more classes in this area

  • Sensory organs

    34.5%
    Corticosteroid34.5%
    Clobetasol Propionate48%Hydrocortisone38%Betamethasone Dipropionate14%
    Part D≥53 patients
  • Cancer & immunology

    9.9%
    Nucleoside Metabolic Inhibitor5.2%
    Fluorouracil100%
    Part D≥28 patients
    Folate Analog Metabolic Inhibitor2.4%
    Methotrexate100%
    Part D<11 patients

    + 1 more class in this area

Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”